[Federal Register Volume 74, Number 18 (Thursday, January 29, 2009)]
[Notices]
[Pages 5170-5171]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-1869]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Methods Manufacturing Cancer Therapeutics.
    Date: February 26, 2009.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Conference Room 406, Rockville, MD 20852 Telephone Conference Call).
    Contact Person: Joyce C. Pegues, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-1286, 
<a href="/cdn-cgi/l/email-protection#c0b0a5a7b5a5b3aa80ada1a9aceeaea9a8eea7afb6"><span class="__cf_email__" data-cfemail="354550524050465f7558545c591b5b5c5d1b525a43">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovations in Cancer Sample Preparation.
    Date: March 11-12, 2009.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Blvd., Room 
8053, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Sherwood Githens, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Room 8053, Bethesda, MD 20892, 301/435-1822, <a href="/cdn-cgi/l/email-protection#35525c415d505b46467558545c591b5b5c5d1b525a43"><span class="__cf_email__" data-cfemail="fa9d938e929f948989ba979b9396d4949392d49d958c">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Anticancer Agents.
    Date: March 12-13, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Thomas M. Vollberg, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activites, National Cancer Institute, NIH, 6116 Executive Boulevard, 
Room 7142, Bethesda, MD 20892, 301-594-9582, <a href="/cdn-cgi/l/email-protection#7c0a1310101e190e083c111d151052121514521b130a"><span class="__cf_email__" data-cfemail="b8ced7d4d4daddcaccf8d5d9d1d496d6d1d096dfd7ce">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Novel Antibody Epitope Mapping Technologies.
    Date: March 17, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).

[[Page 5171]]

    Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Room 8131, Bethesda, MD 20892, 301-594-1402, <a href="/cdn-cgi/l/email-protection#5b37342b3a382c1b363a323775353233753c342d"><span class="__cf_email__" data-cfemail="7f13100f1e1c083f121e16135111161751181009">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Application of Emerging Technologies for Cancer Research.
    Date: March 19-20, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Viatcheslav A. Soldatenkov, MD, PhD, Scientific 
Review Officer, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8050A, Bethesda, MD 20892-8329, 301-451-4758, 
<a href="/cdn-cgi/l/email-protection#2c5f4340484d58494247435a5a6c414d454002424544024b435a"><span class="__cf_email__" data-cfemail="7605191a12170213181d190000361b171f1a58181f1e58111900">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Antibody Array for Cancer Detection.
    Date: March 24, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 
20877.
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7141, Bethesda, MD 20892-7405, 301-496-7575, 
<a href="/cdn-cgi/l/email-protection#3747565b525c56455b775a565e5b19595e5f19505841"><span class="__cf_email__" data-cfemail="e191808d848a80938da18c80888dcf8f8889cf868e97">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-1869 Filed 1-28-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>